Researchers turn to wearable tech in race to track Covid-19

Researchers are turning to wearable technologies such as Fitbits and Apple Watches in a new bid to tackle coronavirus, using them to gather large volumes of real-time patient data to track the course of the disease. Wearable systems work by monitoring “biomarkers” — measures such as heart rate or skin temperature — which can indicate the presence of the virus, even before symptoms are felt.

Read full article here. 

Telehealth could be a game-changer in the fight against COVID-19. Here’s why

Teleconsults are merely the tip of the telehealth iceberg. Other elements include the use of AI chatbots to screen for diseases, predictive analytics to stratify the risk of a population so that proactive care can be targeted at the right groups, remote monitoring in ICUs, general wards and homes so that patients can be continuously and remotely monitored, and the delivery of alerts, reminders and educational materials to patients.

Read full article here.

The five: robots helping to tackle coronavirus

The UN has equipped Rwanda with five anti-epidemic robots made by Belgian company Zora Bots to help against the country’s battle with coronavirus. The robots can screen a patient’s temperature, identify people not wearing masks and monitor abnormalities in how patients sound or look. They can also be used to deliver medicine and other essentials to the infected.

Read full article here. 

Drug innovation is back in fashion

The pandemic has reminded the world of the industry’s strengths—its capacity to innovate and provide drugs on a vast scale. Many of the big firms, such as Johnson & Johnson and Sanofi, are working on covid-19 vaccines and therapies. Scores of smaller companies are at work, too. On May 18th Moderna, an American biotech firm, said that its much-anticipated vaccine has shown positive early results (although some analysts questioned the validity of its tests). AstraZeneca, a big British firm that invests heavily in research and development (r&d), is working on a vaccine with scientists at Oxford University, helped by $1bn of new funding from America’s government. Even before the virus, the industry had started to invest more heavily. In the most recent quarter America’s 30 biggest firms boosted their r&d by a median of 6% year on year. Now medical innovation is back in fashion.

Read full article here.

Beyond telehealth: the virtual care technology trends that will transform healthcare

A recent estimate by consulting firm McKinsey suggests that $250 billion in healthcare spending could shift to virtual care models in the wake of the COVID-19 pandemic.

Notwithstanding the dramatic headline, there is no disputing that we are directionally headed towards a significant shift in the way care is delivered. If anything, the actual shift in spend could be much higher.

Read full article here.

The planet's health is our health: why healthcare must go green

The need to connect the health of people with the planet’s health is the key to driving more sustainable solutions for healthcare, given the vast cost to our well-being of air, water and soil pollution, as reflected by an estimated 9 million premature deaths globally.

By supporting healthy environments, we contribute to a healthier ecosystem and could slow – even prevent – the incidence of disease on a global scale.

Read full article here.

COVID-19 is normalizing telehealth, and that’s a good thing

“Medicare, knowing that all of its beneficiaries, by definition, are high risk, changed the rules and announced that telemedicine could replace in-person visits to reduce the spread of coronavirus. This created a huge opportunity for telemedicine companies to serve a large and brand-new market. Under this new waiver, Medicare now pays for telemedicine at the same rate as in-person visits.”

COVID-19 is normalizing telehealth, and that’s a good thing
https://www.fastcompany.com/90490988/covid-19-is-normalizing-telehealth-and-thats-a-good-thing
via Instapaper